25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Vytrus Biotech S.A.
Buy, Hold or Sell?

Let's analyze Vytrus together

I guess you are interested in Vytrus Biotech S.A.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Vytrus Biotech S.A.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Vytrus Biotech S.A.

I send you an email if I find something interesting about Vytrus Biotech S.A..

Quick analysis of Vytrus (30 sec.)










What can you expect buying and holding a share of Vytrus? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€0.69
Expected worth in 1 year
€2.08
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
€1.38
Return On Investment
53.6%

For what price can you sell your share?

Current Price per Share
€2.58
Expected price per share
€1.86 - €3.215
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Vytrus (5 min.)




Live pricePrice per Share (EOD)

€2.58

2. Growth of Vytrus (5 min.)




Is Vytrus growing?

Current yearPrevious yearGrowGrow %
How rich?$5.1m???

How much money is Vytrus making?

Current yearPrevious yearGrowGrow %
Making money$328.5k???
Net Profit Margin16.4%?--

How much money comes from the company's main activities?

3. Financial Health of Vytrus (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Vytrus? (5 min.)

Welcome investor! Vytrus's management wants to use your money to grow the business. In return you get a share of Vytrus.

What can you expect buying and holding a share of Vytrus?

First you should know what it really means to hold a share of Vytrus. And how you can make/lose money.

Speculation

The Price per Share of Vytrus is €2.58. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vytrus.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vytrus, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.69. Based on the TTM, the Book Value Change Per Share is €0.35 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vytrus.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.041.7%0.051.9%0.051.9%0.051.9%
Usd Book Value Change Per Share0.020.7%0.3814.6%0.3814.6%0.3814.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.020.7%0.3814.6%0.3814.6%0.3814.6%
Usd Price Per Share3.69-3.58-3.58-3.58-
Price to Earnings Ratio21.63-19.01-19.01-19.01-
Price-to-Total Gains Ratio200.65-102.69-102.69-102.69-
Price to Book Ratio4.92-4.83-4.83-4.83-
Price-to-Total Gains Ratio200.65-102.69-102.69-102.69-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.801364
Number of shares356
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.380.38
Usd Total Gains Per Share0.380.38
Gains per Quarter (356 shares)133.70133.70
Gains per Year (356 shares)534.78534.78
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
105355250535525
2010701060010701060
3016041595016041595
4021392130021392130
5026742665026742665
6032093200032093200
7037433735037433735
8042784270042784270
9048134805048134805
10053485340053485340

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.00.00.0100.0%2.00.00.0100.0%2.00.00.0100.0%2.00.00.0100.0%2.00.00.0100.0%
Book Value Change Per Share2.00.00.0100.0%2.00.00.0100.0%2.00.00.0100.0%2.00.00.0100.0%2.00.00.0100.0%
Dividend per Share0.00.02.00.0%0.00.02.00.0%0.00.02.00.0%0.00.02.00.0%0.00.02.00.0%
Total Gains per Share2.00.00.0100.0%2.00.00.0100.0%2.00.00.0100.0%2.00.00.0100.0%2.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Vytrus

About Vytrus Biotech S.A.

Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells for the cosmetic sector primarily in Spain. It offers Nectaria Lithops, an active ingredient that biophysically optimizes the skin microenvironment and vitamin D levels; Photobiome a microbiota photoprotector; Olea Vitae cellular oil for ageing; Turmeria Zen for skin hydration and wrinkles on stressed profiles; Sensia Carota, a plant-based active that protects and prevents from the damage on sensitive and sensitized skins; Deobiome Noni, a biological deodorant; and Sarcoslim Re-Shape to reduce fat on tissue. The company also offers Capilia Longa for hair growth reactivation; Luminia Granatum for skin brightening;Elaya Renova a hair tensegrist; Kannabia Sense that stimulates the microbiota-skin-brain axis; Quora Noni to avoid the attack of skin harmful bacteria; Quora Noni biomics for rejuvenating the skin microbiota; Centella Reversa for facial complexion improvement; and Arabian Cotton for protection against photo-ageing. It sells its products to approximately 560 countries. Vytrus Biotech, S.A. was incorporated in 2009 and is based in Barcelona, Spain.

Fundamental data was last updated by Penke on 2024-07-13 07:19:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Vytrus Biotech S.A..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Vytrus earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Vytrus to the Biotechnology industry mean.
  • A Net Profit Margin of 16.4% means that €0.16 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vytrus Biotech S.A.:

  • The MRQ is 16.4%. The company is making a huge profit. +2
  • The TTM is 16.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ16.4%TTM16.4%+0.0%
TTM16.4%5Y16.4%0.0%
5Y16.4%10Y16.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ16.4%-168.6%+185.0%
TTM16.4%-209.9%+226.3%
5Y16.4%-390.8%+407.2%
10Y16.4%-505.1%+521.5%
1.1.2. Return on Assets

Shows how efficient Vytrus is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vytrus to the Biotechnology industry mean.
  • 3.4% Return on Assets means that Vytrus generated €0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vytrus Biotech S.A.:

  • The MRQ is 3.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.4%TTM3.9%-0.5%
TTM3.9%5Y3.9%0.0%
5Y3.9%10Y3.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4%-11.7%+15.1%
TTM3.9%-11.8%+15.7%
5Y3.9%-13.2%+17.1%
10Y3.9%-14.6%+18.5%
1.1.3. Return on Equity

Shows how efficient Vytrus is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vytrus to the Biotechnology industry mean.
  • 5.7% Return on Equity means Vytrus generated €0.06 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vytrus Biotech S.A.:

  • The MRQ is 5.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 6.5%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.7%TTM6.5%-0.8%
TTM6.5%5Y6.5%0.0%
5Y6.5%10Y6.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.7%-14.0%+19.7%
TTM6.5%-15.2%+21.7%
5Y6.5%-18.8%+25.3%
10Y6.5%-19.3%+25.8%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Vytrus Biotech S.A..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Vytrus is operating .

  • Measures how much profit Vytrus makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vytrus to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vytrus Biotech S.A.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--351.1%+351.1%
TTM--224.3%+224.3%
5Y--396.3%+396.3%
10Y--510.1%+510.1%
1.2.2. Operating Ratio

Measures how efficient Vytrus is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.16 means that the operating costs are €0.16 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Vytrus Biotech S.A.:

  • The MRQ is 0.163. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.175. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.163TTM0.175-0.012
TTM0.1755Y0.1750.000
5Y0.17510Y0.1750.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1633.004-2.841
TTM0.1753.255-3.080
5Y0.1755.004-4.829
10Y0.1756.533-6.358
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Vytrus Biotech S.A..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Vytrus is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.33 means the company has €1.33 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Vytrus Biotech S.A.:

  • The MRQ is 1.327. The company is just able to pay all its short-term debts.
  • The TTM is 1.770. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.327TTM1.770-0.444
TTM1.7705Y1.7700.000
5Y1.77010Y1.7700.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3273.793-2.466
TTM1.7704.052-2.282
5Y1.7705.990-4.220
10Y1.7706.326-4.556
1.3.2. Quick Ratio

Measures if Vytrus is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vytrus to the Biotechnology industry mean.
  • A Quick Ratio of 0.97 means the company can pay off €0.97 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vytrus Biotech S.A.:

  • The MRQ is 0.970. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.328. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ0.970TTM1.328-0.358
TTM1.3285Y1.3280.000
5Y1.32810Y1.3280.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9703.186-2.216
TTM1.3283.581-2.253
5Y1.3285.922-4.594
10Y1.3286.430-5.102
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Vytrus Biotech S.A..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Vytrus assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vytrus to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.41 means that Vytrus assets are financed with 40.6% credit (debt) and the remaining percentage (100% - 40.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vytrus Biotech S.A.:

  • The MRQ is 0.406. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.398. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.406TTM0.398+0.008
TTM0.3985Y0.3980.000
5Y0.39810Y0.3980.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4060.330+0.076
TTM0.3980.340+0.058
5Y0.3980.368+0.030
10Y0.3980.383+0.015
1.4.2. Debt to Equity Ratio

Measures if Vytrus is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vytrus to the Biotechnology industry mean.
  • A Debt to Equity ratio of 68.4% means that company has €0.68 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vytrus Biotech S.A.:

  • The MRQ is 0.684. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.663. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.684TTM0.663+0.021
TTM0.6635Y0.6630.000
5Y0.66310Y0.6630.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6840.366+0.318
TTM0.6630.415+0.248
5Y0.6630.441+0.222
10Y0.6630.483+0.180
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Vytrus Biotech S.A.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Vytrus generates.

  • Above 15 is considered overpriced but always compare Vytrus to the Biotechnology industry mean.
  • A PE ratio of 21.63 means the investor is paying €21.63 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vytrus Biotech S.A.:

  • The EOD is 16.415. Based on the earnings, the company is fair priced.
  • The MRQ is 21.633. Based on the earnings, the company is fair priced.
  • The TTM is 19.015. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD16.415MRQ21.633-5.217
MRQ21.633TTM19.015+2.618
TTM19.0155Y19.0150.000
5Y19.01510Y19.0150.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD16.415-2.571+18.986
MRQ21.633-3.020+24.653
TTM19.015-2.891+21.906
5Y19.015-6.222+25.237
10Y19.015-6.317+25.332
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vytrus Biotech S.A.:

  • The EOD is -16.500. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -21.745. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -35.357. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-16.500MRQ-21.745+5.244
MRQ-21.745TTM-35.357+13.612
TTM-35.3575Y-35.3570.000
5Y-35.35710Y-35.3570.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-16.500-3.225-13.275
MRQ-21.745-3.748-17.997
TTM-35.357-3.717-31.640
5Y-35.357-7.998-27.359
10Y-35.357-8.522-26.835
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Vytrus is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 4.92 means the investor is paying €4.92 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Vytrus Biotech S.A.:

  • The EOD is 3.730. Based on the equity, the company is fair priced.
  • The MRQ is 4.915. Based on the equity, the company is fair priced.
  • The TTM is 4.829. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.730MRQ4.915-1.185
MRQ4.915TTM4.829+0.086
TTM4.8295Y4.8290.000
5Y4.82910Y4.8290.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.7301.936+1.794
MRQ4.9152.247+2.668
TTM4.8292.301+2.528
5Y4.8293.666+1.163
10Y4.8294.139+0.690
2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Vytrus Biotech S.A. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0170.346-95%--0.346-95%0.346-95%
Book Value Per Share--0.6920.683+1%--0.683+1%0.683+1%
Current Ratio--1.3271.770-25%--1.770-25%1.770-25%
Debt To Asset Ratio--0.4060.398+2%--0.398+2%0.398+2%
Debt To Equity Ratio--0.6840.663+3%--0.663+3%0.663+3%
Dividend Per Share----0%---0%-0%
Eps--0.0390.044-11%--0.044-11%0.044-11%
Free Cash Flow Per Share---0.039-0.028-29%---0.028-29%-0.028-29%
Free Cash Flow To Equity Per Share---0.077-0.052-32%---0.052-32%-0.052-32%
Gross Profit Margin--1.0001.0000%--1.0000%1.0000%
Market Cap17728650.600-32%23363338.00022676181.000+3%--22676181.000+3%22676181.000+3%
Net Profit Margin--0.1640.164+0%--0.164+0%0.164+0%
Operating Margin----0%---0%-0%
Operating Ratio--0.1630.175-7%--0.175-7%0.175-7%
Pb Ratio3.730-32%4.9154.829+2%--4.829+2%4.829+2%
Pe Ratio16.415-32%21.63319.015+14%--19.015+14%19.015+14%
Price Per Share2.580-32%3.4003.300+3%--3.300+3%3.300+3%
Price To Free Cash Flow Ratio-16.500+24%-21.745-35.357+63%---35.357+63%-35.357+63%
Price To Total Gains Ratio152.256-32%200.647102.695+95%--102.695+95%102.695+95%
Quick Ratio--0.9701.328-27%--1.328-27%1.328-27%
Return On Assets--0.0340.039-13%--0.039-13%0.039-13%
Return On Equity--0.0570.065-12%--0.065-12%0.065-12%
Total Gains Per Share--0.0170.346-95%--0.346-95%0.346-95%
Usd Book Value--5161230.8625098015.586+1%--5098015.586+1%5098015.586+1%
Usd Book Value Change Per Share--0.0180.376-95%--0.376-95%0.376-95%
Usd Book Value Per Share--0.7510.742+1%--0.742+1%0.742+1%
Usd Dividend Per Share----0%---0%-0%
Usd Eps--0.0430.048-11%--0.048-11%0.048-11%
Usd Free Cash Flow---291656.738-206774.323-29%---206774.323-29%-206774.323-29%
Usd Free Cash Flow Per Share---0.042-0.030-29%---0.030-29%-0.030-29%
Usd Free Cash Flow To Equity Per Share---0.083-0.056-32%---0.056-32%-0.056-32%
Usd Market Cap19249768.821-32%25367912.40024621797.330+3%--24621797.330+3%24621797.330+3%
Usd Price Per Share2.801-32%3.6923.583+3%--3.583+3%3.583+3%
Usd Profit--293166.000328595.654-11%--328595.654-11%328595.654-11%
Usd Revenue--1782742.4461999191.247-11%--1999191.247-11%1999191.247-11%
Usd Total Gains Per Share--0.0180.376-95%--0.376-95%0.376-95%
 EOD+3 -5MRQTTM+9 -23YOY+0 -05Y+9 -2310Y+9 -23

3.2. Fundamental Score

Let's check the fundamental score of Vytrus Biotech S.A. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1516.415
Price to Book Ratio (EOD)Between0-13.730
Net Profit Margin (MRQ)Greater than00.164
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.970
Current Ratio (MRQ)Greater than11.327
Debt to Asset Ratio (MRQ)Less than10.406
Debt to Equity Ratio (MRQ)Less than10.684
Return on Equity (MRQ)Greater than0.150.057
Return on Assets (MRQ)Greater than0.050.034
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Vytrus Biotech S.A. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than502.064
Ma 20Greater thanMa 503.056
Ma 50Greater thanMa 1003.152
Ma 100Greater thanMa 2003.189
OpenGreater thanClose2.600
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets8,004
Total Liabilities3,250
Total Stockholder Equity4,753
 As reported
Total Liabilities 3,250
Total Stockholder Equity+ 4,753
Total Assets = 8,004

Assets

Total Assets8,004
Total Current Assets1,683
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 725
Net Receivables 506
Inventory 428
Total Current Assets  (as reported)1,683
Total Current Assets  (calculated)1,659
+/- 25
Long-term Assets
Property Plant Equipment 1,026
Intangible Assets 3,152
Long-term Assets  (as reported)0
Long-term Assets  (calculated)4,179
+/- 4,179

Liabilities & Shareholders' Equity

Total Current Liabilities1,269
Long-term Liabilities0
Total Stockholder Equity4,753
Total Current Liabilities
Total Current Liabilities  (as reported)1,269
Total Current Liabilities  (calculated)0
+/- 1,269
Long-term Liabilities
Long term Debt Total 735
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)735
+/- 735
Total Stockholder Equity
Retained Earnings 1,518
Capital Surplus 3,401
Total Stockholder Equity (as reported)4,753
Total Stockholder Equity (calculated)4,919
+/- 166
Other
Cash and Short Term Investments 725
Common Stock Shares Outstanding 6,844
Liabilities and Stockholders Equity 8,004
Net Working Capital 414



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-12-312022-06-30
> Total Assets 
7,611
8,004
8,0047,611
   > Total Current Assets 
1,861
1,683
1,6831,861
       Cash And Cash Equivalents 
1,065
725
7251,065
       Short-term Investments 
1
0
01
       Net Receivables 
350
506
506350
       Inventory 
412
428
428412
   > Long-term Assets 00
       Property Plant Equipment 
871
1,026
1,026871
       Intangible Assets 
2,920
3,152
3,1522,920
> Total Liabilities 
2,974
3,250
3,2502,974
   > Total Current Liabilities 
840
1,269
1,269840
   > Long-term Liabilities 00
       Long term Debt Total 
629
735
735629
> Total Stockholder Equity
4,637
4,753
4,7534,637
   Retained Earnings 
1,246
1,518
1,5181,246
   Accumulated Other Comprehensive Income 00
   Capital Surplus 
3,401
3,401
3,4013,401
   Treasury Stock00



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue3,682
Cost of Revenue-651
Gross Profit3,0323,032
 
Operating Income (+$)
Gross Profit3,032
Operating Expense-0
Operating Income6453,032
 
Operating Expense (+$)
Research Development0
Selling General Administrative1,775
Selling And Marketing Expenses0
Operating Expense01,775
 
Net Interest Income (+$)
Interest Income192
Interest Expense-0
Other Finance Cost-192
Net Interest Income0
 
Pretax Income (+$)
Operating Income645
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)453645
EBIT - interestExpense = 0
605
605
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0453
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax453
Tax Provision--152
Net Income From Continuing Ops0605
Net Income605
Net Income Applicable To Common Shares605
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net00
 

Technical Analysis of Vytrus
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vytrus. The general trend of Vytrus is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vytrus's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vytrus Biotech S.A..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.215 < 3.215 < 3.215.

The bearish price targets are: 2.28 > 1.86.

Tweet this
Vytrus Biotech S.A. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vytrus Biotech S.A.. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vytrus Biotech S.A. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vytrus Biotech S.A.. The current macd is -0.15613202.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Vytrus price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Vytrus. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Vytrus price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Vytrus Biotech S.A. Daily Moving Average Convergence/Divergence (MACD) ChartVytrus Biotech S.A. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vytrus Biotech S.A.. The current adx is 32.39.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Vytrus shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Vytrus Biotech S.A. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vytrus Biotech S.A.. The current sar is 3.17765692.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Vytrus Biotech S.A. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vytrus Biotech S.A.. The current rsi is 2.06411186. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Vytrus Biotech S.A. Daily Relative Strength Index (RSI) ChartVytrus Biotech S.A. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vytrus Biotech S.A.. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Vytrus price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Vytrus Biotech S.A. Daily Stochastic Oscillator ChartVytrus Biotech S.A. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vytrus Biotech S.A.. The current cci is -133.33333333.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Vytrus Biotech S.A. Daily Commodity Channel Index (CCI) ChartVytrus Biotech S.A. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vytrus Biotech S.A.. The current cmo is -99.64694606.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Vytrus Biotech S.A. Daily Chande Momentum Oscillator (CMO) ChartVytrus Biotech S.A. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vytrus Biotech S.A.. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Vytrus Biotech S.A. Daily Williams %R ChartVytrus Biotech S.A. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Vytrus Biotech S.A..

Vytrus Biotech S.A. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vytrus Biotech S.A.. The current atr is 0.04024967.

Vytrus Biotech S.A. Daily Average True Range (ATR) ChartVytrus Biotech S.A. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vytrus Biotech S.A.. The current obv is 74,572.

Vytrus Biotech S.A. Daily On-Balance Volume (OBV) ChartVytrus Biotech S.A. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vytrus Biotech S.A.. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Vytrus Biotech S.A. Daily Money Flow Index (MFI) ChartVytrus Biotech S.A. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vytrus Biotech S.A..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-04-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Vytrus Biotech S.A. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vytrus Biotech S.A. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than502.064
Ma 20Greater thanMa 503.056
Ma 50Greater thanMa 1003.152
Ma 100Greater thanMa 2003.189
OpenGreater thanClose2.600
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Vytrus with someone you think should read this too:
  • Are you bullish or bearish on Vytrus? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vytrus? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vytrus Biotech S.A.

I send you an email if I find something interesting about Vytrus Biotech S.A..


Comments

How you think about this?

Leave a comment

Stay informed about Vytrus Biotech S.A..

Receive notifications about Vytrus Biotech S.A. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.